Your browser doesn't support javascript.
loading
Using principal stratification in analysis of clinical trials.
Lipkovich, Ilya; Ratitch, Bohdana; Qu, Yongming; Zhang, Xiang; Shan, Mingyang; Mallinckrodt, Craig.
Afiliación
  • Lipkovich I; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Ratitch B; Bayer, Montreal, Quebec, Canada.
  • Qu Y; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Zhang X; CSL Behring, King of Prussia, Pennsylvania, USA.
  • Shan M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Mallinckrodt C; Pentara, Millcreek, Utah, USA.
Stat Med ; 41(19): 3837-3877, 2022 Aug 30.
Article en En | MEDLINE | ID: mdl-35851717
ABSTRACT
The ICH E9(R1) addendum (2019) proposed principal stratification (PS) as one of five strategies for dealing with intercurrent events. Therefore, understanding the strengths, limitations, and assumptions of PS is important for the broad community of clinical trialists. Many approaches have been developed under the general framework of PS in different areas of research, including experimental and observational studies. These diverse applications have utilized a diverse set of tools and assumptions. Thus, need exists to present these approaches in a unifying manner. The goal of this tutorial is threefold. First, we provide a coherent and unifying description of PS. Second, we emphasize that estimation of effects within PS relies on strong assumptions and we thoroughly examine the consequences of these assumptions to understand in which situations certain assumptions are reasonable. Finally, we provide an overview of a variety of key methods for PS analysis and use a real clinical trial example to illustrate them. Examples of code for implementation of some of these approaches are given in Supplemental Materials.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Stat Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Stat Med Año: 2022 Tipo del documento: Article